Home › Ulcerative Colitis › Florida › Sarasota
Ulcerative Colitis clinical trials in Sarasota, FL
4 studies for Ulcerative Colitis are looking for participants at sites in and around Sarasota (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
RecruitingPhase 2
- Florida Research Institute, Lakewood Rch · 7 mi away
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Florida Research Institute, Lakewood Rch · 7 mi away
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RecruitingPhase 2
- Florida Research Institute, Lakewood Rch · 7 mi away
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- Florida Research Center Inc., Lakewood Rch · 7 mi away
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- Orlando, FL21 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Houston, TX14 studies
- San Diego, CA13 studies
- Chicago, IL13 studies
- Tacoma, WA13 studies
- St. Louis, MO13 studies
- Tyler, TX13 studies
- San Antonio, TX13 studies
- Colorado Springs, CO12 studies
- Boston, MA12 studies
Other studies in Sarasota
- Metastatic Cancer17 studies
- Non-Small Cell Lung Cancer17 studies
- Colorectal Cancer15 studies
- Ovarian Cancer14 studies
- Breast Cancer12 studies
- Endometrial Cancer12 studies
- Cancer (all types)10 studies
- Triple-Negative Breast Cancer8 studies
- Lung Cancer8 studies
- Pancreatic Cancer7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Atrial Fibrillation6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.